| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |